Giles Platford | President, International BU

Giles Platford is the president of the International Business Unit (IBU) where he directly oversees all markets outside of the U.S., with the goal of better positioning the company for long-term growth and maximizing the patient impact of Takeda’s current and future portfolio across diverse international markets.

Giles joined Takeda in 2009 as general manager of Brazil and later took on the role of area head for Middle East, Turkey & Africa. He then joined the Takeda Executive Team in 2014 as president of Emerging Markets. In 2017, he became president of Europe & Canada, where he also represented Takeda as a board member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). In 2022 he became president of the Plasma-Derived Therapies Business Unit, where he also represented the company as chair of the global executive board for the Plasma Protein Therapeutics Association (PPTA).

Giles also serves as a board member of the Healthcare Businesswomen’s Association.

Prior to joining Takeda, Giles spent eight years in Asia Pacific, where he held a number of roles of increasing responsibility in Business Development, Commercial and General Management.

Giles holds a Bachelor of Arts degree in business and marketing management from Oxford Brookes University, UK, and is currently based in Tokyo, Japan.